|本期目录/Table of Contents|

[1]郑晴晴 王剑 阳韬.外泌体miRNA对肺结节的诊断进展[J].中华肺部疾病杂志,2023,(02):293-295.[doi:10.3877/cma.j.issn.1674-6902.2023.02.040 ]
点击复制

外泌体miRNA对肺结节的诊断进展(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2023年02期
页码:
293-295
栏目:
综述
出版日期:
2023-04-20

文章信息/Info

Title:
-
作者:
郑晴晴1 王剑2 阳韬23
212002 镇江,江苏大学医学院1 212002 镇江,江苏大学附属人民医院·镇江市第一人民医院呼吸及危重症学科2 210029 南京,南京医科大学第一附属医院·江苏省人民医院3
Author(s):
-
关键词:
肺结节 外泌体miRNA 诊断进展
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2023.02.040
摘要:
-
Abstract:
-

参考文献/References:

1 Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule: A review[J]. JAMA, 2022, 327(3): 264-273.
2 Liu QX, Zhou D, Han TC, et al. A noninvasive multianalytical approach for lung cancer diagnosis of patients with pulmonary nodules[J]. Adv Sci(Weinh), 2021, 8(13): 2100104.
3 Chen K, Kang G, Zhao H, et al. Liquid biopsy in newly diagnosed patients with locoregional(Ⅰ-ⅢA)non-small cell lung cancer[J]. Expert Rev Mol Diagn, 2019, 19(5): 419-427.
4 Xu K, Zhang C, Du T, et al. Progress of exosomes in the diagnosis and treatment of lung cancer[J]. Biomed Pharmacother, 2021, 134: 111111.
5 Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function?[J]. Genomics Proteomics Bioinformatics, 2015, 13(1): 17-24.
6 Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of microRNA expression in cancer[J]. Int J Mol Sci, 2020, 21(5): 1723.
7 ElKashef SMMAE, Ahmad SE, Soliman YMA, et al. Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma[J]. Innate Immun, 2021, 27(1): 61-69.
8 Njock MS, Guiot J, Henket MA, et al. Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis[J]. Thorax, 2019, 74(3): 309-312.
9 Jiang F, Chen Q, Wang W, et al. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1[J]. J Hepatol, 2020, 72(1): 156-166.
10 Ying W, Gao H, Dos Reis FCG, et al. MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice[J]. Cell Metab, 2021, 33(4): 781-790.
11 Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics[J]. Theranostics, 2020, 10(8): 3684-3707.
12 Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: Formation-function-future[J]. Int J Mol Sci, 2016, 17(12): 2028.
13 Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications[J]. Mol Cancer, 2018, 17(1): 147.
14 Coughlan C, Bruce KD, Burgy O, et al. Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses[J]. Curr Protoc Cell Biol, 2020, 88(1): e110.
15 Shirejini SZ, Inci F. The Yin and Yang of exosome isolation methods: conventional practice, microfluidics, and commercial kits[J]. Biotechnol Adv, 2022, 54: 107814.
16 Lin S, Yu Z, Chen D, et al. Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications[J]. Small, 2020, 16(9): e1903916.
17 刘 亮, 肖 瑶, 张 驰. miRNA检测方法的研究进展[J]. 药物分析杂志, 2020, 40(1): 70-82.
18 Hu T, Chitnis N, Monos D, et al. Next-generation sequencing technologies: An overview[J]. Hum Immunol, 2021, 82(11): 801-811.
19 Zheng D, Zhu Y, Zhang J, et al. Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules[J]. J Nanobiotechnol, 2022, 20(1): 172.
20 Yang G, Wang T, Qu X, et al. Exosomal miR-21/Let-7a ratio distinguishes non-small cell lung cancer from benign pulmonary diseases[J]. Asia Pac J Clin Oncol, 2020, 16(4): 280-286.
21 Zhou X, Wen W, Shan X, et al. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis[J]. Oncotarget, 2017, 8(4): 6513-6525.
22 Jin X, Chen Y, Chen H, et al. Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing[J]. Clin Cancer Res, 2017, 23(17): 5311-5319.
23 Cazzoli R, Buttitta F, Di Nicola M, et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer[J]. J Thorac Oncol, 2013, 8(9): 1156-1162.
24 Zhao Z, Liu J, Wang C, et al. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2[J]. Int J Clin Exp Pathol, 2014, 7(11): 7726-7734.
25 Shen J, Liu Z, Todd NW, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers[J]. BMC Cancer, 2011, 11: 374.
26 Xianfeng Li, Qinghua Zhang, Xiayun Jin, et al. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study[J]. World J Surg Oncol, 2017, 15(1): 107.
27 Xing L, Su J, Guarnera MA, et al. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules[J]. Clin Cancer Res, 2015, 21(2): 484-489.
28 Zhou P, Lu F, Wang J, et al. A portable point-of-care testing system to diagnose lung cancer through the detection of exosomal miRNA in urine and saliva[J]. Chem Commun(Camb), 2020, 56(63): 8968-8971.
29 范卫杰, 张 冬. 影像组学及深度学习在肺结节良恶性鉴别诊断中的新理念[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(5): 549-553.
30 杨 丽, 钱桂生. 肺结节临床精准诊断的新理念[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 1-5.
31 Piao XM, Jeong P, Kim YH, et al. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria[J]. Int J Cancer, 2019, 144(2): 380-388.
32 Salahandish R, Ghaffarinejad A, Omidinia E, et al. Label-free ultrasensitive detection of breast cancer miRNA-21 biomarker employing electrochemical nano-genosensor based on sandwiched AgNPs in PANI and N-doped graphene[J]. Biosens Bioelectron, 2018, 120: 129-136.

备注/Memo

备注/Memo:
基金项目: 镇江市社会发展项目(SH2020047)
通信作者: 王 剑, Email: wj65812@163.com
阳 韬, Email: ouyangtao1986@126.com
更新日期/Last Update: 2023-04-20